Imagilys

Imagilys develops and sells neuroimaging and neurostimulation systems. One asset diffe-rentiates us from most of our competitors: we focus exclusively on the brain, whereas they sell generic whole-body workstations. BrainMagix, our neuroimaging software, is the result of 12 years of research and development. We help our customers, throughout the world, to diagnose and to cure patients with severe neurological, neurosurgical and psychiatric diseases. We help pharmaceutical companies and CROs to use the most advanced biomarkers for the discovery of promising drugs. We collaborate with experts at Harvard and Johns Hopkins University. We benefit from the continuous support of the Brussels-Capital Region. Each year, we train our customers to the state-of-the-art of neuroimaging techniques, during our Advanced Clinical Neuroimaging Course.

You may also be interested by :

How to conduct a market study? Market study research is one of the most important steps when launching a new project. Indeed, before doing anything else,…

I need financial support to protect my idea? Who to turn to? Having your idea protected is an important investment for which the return on investment, although almost certainly, only comes in…

I’m looking for funds to export my business. Who to turn to? Getting started on foreign markets is an important phase in the lifecycle of a company. This phase needs the implementation…

My company has an innovation project. How to finance… In the health sector, it is often the case that a project leader needs to build a prototype before launching…

The Brussels project StellaScreen wins the first… lifetech.brussels, MedTech Flanders and Medtech Wallonia joined forces to set up the MedTech Accelerator®, a 4-month program dedicated to boosting…

e-Health in Brussels: a blooming sector During the Brussels e-health week, the minister of Economy Didier Gosuin, shared his vision for e-health as a sector of…